Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01679301 · ClinicalTrials.gov registry record · NA
Evaluation of Sleep Mode Within the Respironics SimplyGo Portable Oxygen Concentrator
A NA study, sponsored by Philips Respironics.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
NCT01679301 is a NA study that has completed, run by Philips Respironics. The registered enrollment target is 11 participants.
The verdict
NCT01679301, a NA study, has completed, sponsored by Philips Respironics.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
Study Summary
The SimplyGo Study is a single site, cross-over study which aims to enroll a maximum of 30 participants (to allow for 20 completed data sets) with a prescription for nocturnal oxygen, and meeting all eligibility criteria.
Interventions
- DEVICE Pulse Dose (Sleep Mode)
- DEVICE Continuous Dose
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2012-09 |
| Est. Completion | 2014-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01679301
The ClinicalTrials.gov registry entry for NCT01679301 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Respironics, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Pulse Dose (Sleep Mode) is the first listed.
NCT01679301 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01679301 about?
NCT01679301 is a clinical study titled "Evaluation of Sleep Mode Within the Respironics SimplyGo Portable Oxygen Concentrator". The SimplyGo Study is a single site, cross-over study which aims to enroll a maximum of 30 participants (to allow for 20 completed data sets) with a prescription for nocturnal oxygen, and meeting all eligibility criteria.
What is the current status of trial NCT01679301?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2012-09. Estimated completion is 2014-07.
What interventions are being tested in trial NCT01679301?
The interventions under investigation include: Pulse Dose (Sleep Mode) (DEVICE), Continuous Dose (DEVICE).
Who is sponsoring clinical trial NCT01679301?
This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.